Viewing nowSimvastatin 20 mg Tablet
Simvastatin 20mg
Tablet · Prescription medication
iQure Co., Ltd.

MFDS item code 201601571 · Approved 2016.03.18
Improvement of hyperlipidemia; improvement of familial hypercholesterolemia in children; prevention of cardiovascular disease
This medication helps reduce the risk of cardiovascular diseases. It lowers the risk of major cardiovascular events such as coronary heart disease and stroke, and it is effective in patients with diabetes and peripheral vascular disease. Additionally, it reduces the risk of complications that may occur after coronary and non-coronary vascular interventions. It is also used in the treatment of hyperlipidemia, contributing to the reduction of total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels, while increasing HDL cholesterol. In particular, it aids in lipid control for patients with familial dyslipidemia and is used in the treatment of children with heterozygous familial hypercholesterolemia. In summary, this drug is effectively used for the prevention of cardiovascular diseases and the management of hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. Administration of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately based on the initial LDL-cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if cholesterol levels fall below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer to the information below for recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Drug Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not possible. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is used concomitantly in patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg daily. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is used concomitantly in patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is used concomitantly with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg daily. (6) Administration to patients with renal impairment Because this medicine is not excreted extensively by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg daily and monitor carefully.
Ages 10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, with a recommended maximum dose of 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This drug is primarily used to lower cholesterol levels. Muscle problems may occur during treatment, such as muscle pain or weakness, and in severe cases, it may lead to rhabdomyolysis, a serious muscle injury. These muscle issues may occur more frequently as the drug dosage increases, so caution is especially needed when taking high doses. Additionally, as this drug is metabolized in the liver, patients with poor liver function should not take it and should have regular liver function tests. Pregnant or breastfeeding women should not take this drug, and women of childbearing age must use contraception before taking it. The risk of muscle injury can increase when taken with certain medications, so patients should inform their doctor or pharmacist if they are taking other drugs. Particular caution is needed when combined with strong CYP3A4 inhibitors, fibrate medications, certain antibiotics, calcium channel blockers, and others. If unexplained muscle pain, tenderness, or weakness occurs during treatment, immediately inform a healthcare professional. Elderly patients, women, those with hypothyroidism, and patients with impaired kidney function are at a higher risk for muscle issues when taking this drug and should be monitored closely. This drug can rarely cause various adverse reactions such as hepatitis, jaundice, skin rash, and thrombocytopenia; if any unusual symptoms occur, immediate consultation with a physician is necessary. Additionally, grapefruit juice can elevate drug concentrations and increase the risk of side effects, so it should be avoided during treatment. This drug is not used in children, especially those under 10 years of age or pre-pubertal females, as its safety has not been established. There is no specific treatment for overdose, but general emergency care should be administered, and the medical institution should be visited immediately. Finally, this drug should be stored in its original container and kept away from children's reach.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to air and moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature.
Light yellow oval film-coated tablet
30 tablets, 100 tablets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
iQure Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.